Herpes zoster, commonly known as shingles, is a painful condition caused by the reactivation of the varicella-zoster virus, the same virus that causes chickenpox. Fortunately, vaccines are available to help prevent this debilitating condition. Understanding the benefits of the herpes zoster vaccine can encourage more individuals to get vaccinated and protect themselves from shingles.
What is the Herpes Zoster Vaccine?
The herpes zoster vaccine is designed to reduce the risk of developing shingles. There are two main vaccines available: Shingrix and Zostavax. Shingrix is the preferred vaccine due to its higher efficacy rates.
Who Should Get the Herpes Zoster Vaccine?
Herpes Zoster Vaccine Schedule
The Centers for Disease Control and Prevention (CDC) recommends that adults aged 50 and older receive the Shingrix vaccine. The vaccine is administered in two doses, with the second dose given two to six months after the first.
Herpes Zoster Vaccine Age
Even though shingles can occur in younger individuals, the risk increases with age. Therefore, it is strongly advised that individuals begin vaccination at age 50. However, people with certain medical conditions or weakened immune systems may need to consult their healthcare provider for personalized advice.
Get a second opinion from trusted experts and makeconfident, informed decisions.
The primary benefit of the herpes zoster vaccine is the prevention of shingles. Shingrix has been shown to be over 90% effective in preventing shingles and its painful complications, such as postherpetic neuralgia (PHN), a chronic pain condition.
Improved Quality of Life
By preventing shingles, the vaccine helps improve the quality of life for older adults. Shingles can cause severe pain, itching, and sensitivity that can last for months. Preventing these symptoms allows individuals to maintain their daily activities without interruption.
Considerations and Possible Side Effects
Herpes Zoster Vaccine Contraindications
There are some contraindications to consider before getting the vaccine. Individuals with a severe allergic reaction to any component of the vaccine should avoid it. Additionally, people who are pregnant or have a weakened immune system should consult their healthcare provider.
Herpes Zoster Vaccine Side Effects
Like all vaccines, the herpes zoster vaccine can have side effects. Common side effects include redness, swelling, and pain at the injection site. Some people may also experience muscle pain, tiredness, headache, shivering, fever, or upset stomach. These side effects are generally mild and resolve on their own.
Your health is everything - prioritize your well-being today.
When comparing Shingrix vs Zostavax, Shingrix is generally preferred due to its higher efficacy and longer-lasting protection. While Zostavax is a live attenuated vaccine, Shingrix is a non-live recombinant vaccine, making it suitable for a broader range of individuals, including those with compromised immune systems.
Herpes Zoster Vaccine Price in India
The cost of the Herpes Zoster Vaccine (Shingrix) in India typically ranges between ₹15,000 to ₹18,000 for the two-dose regimen. Shingrix, launched by GlaxoSmithKline (GSK), is recommended for adults aged 50 years and above to prevent shingles and its complications such as post-herpetic neuralgia.
Conclusion
The herpes zoster vaccine offers significant benefits by preventing shingles and its complications. With minimal side effects and strong efficacy, it is a valuable tool in maintaining health and quality of life, especially for older adults. Consult your healthcare provider to discuss the best vaccination schedule for you.
Frequently Asked Questions
The age at which the shingles vaccine is free varies depending on the country and its healthcare policies. there may be specific age groups eligible for free vaccination under public health programs.
The shingles vaccine is typically given in two doses. The second dose is administered 2 to 6 months after the first dose. Currently, there is no recommendation for booster doses after the initial two-dose series.
The herpes zoster vaccine is generally recommended for adults aged 50 and older. Eligibility criteria may vary based on specific health conditions, and individuals should consult their healthcare provider for personalized recommendations.
The recommended shingles vaccine, Shingrix, is administered in two doses. The second dose is given 2 to 6 months after the first dose.
Herpes zoster itself is not spread from person to person. However, the virus that causes herpes zoster (varicella-zoster virus) can spread from a person with active shingles to someone who has never had chickenpox or the chickenpox vaccine,
causing them to develop chickenpox.
Herpes zoster spreads through direct contact with the fluid from the blisters of a person with active shingles. It can cause chickenpox in individuals who are not immune to the varicella-zoster virus.
Disclaimer: The information provided is accurate and up-to-date to the best of our knowledge. However, it should not be considered a substitute for medical advice or consultation. We do not guarantee its completeness or accuracy. The absence of specific warnings does not mean a medicine is safe for all users. We are not responsible for any outcomes based on this information and strongly recommend consulting a doctor for any medical concerns or questions.